Clinical advances on chimeric antigen receptor T cell therapy for glioblastoma
Chimeric antigen receptor T cell (CAR⁃T) is a kind of genetically engineered T cells that can express tumor⁃associated antigen (TAA) specific receptors on its surface. The modified T cells can be used for cancer therapy by targeting its specific receptor and killing tumor cells with its cytotoxicity...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tianjin Huanhu Hospital
2020-02-01
|
| Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
| Subjects: | |
| Online Access: | http://www.cjcnn.org/index.php/cjcnn/article/view/2090 |